1	1	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Introduction	_	_	NN	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	Flavivirus	_	_	NNP	_	_	_	_	_
3	genus	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	family	_	_	NN	_	_	_	_	_
7	Flaviviridae	_	_	NNP	_	_	_	_	_
8	includes	_	_	VBZ	_	_	_	_	_
9	several	_	_	JJ	_	_	_	_	_
10	arthropod-borne	_	_	JJ	_	_	_	_	_
11	human	_	_	JJ	_	_	_	_	_
12	pathogens	_	_	NNS	_	_	_	_	_
13	that	_	_	WDT	_	_	_	_	_
14	may	_	_	MD	_	_	_	_	_
15	cause	_	_	VB	_	_	_	_	_
16	a	_	_	DT	_	_	_	_	_
17	spectrum	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	clinical	_	_	JJ	_	_	_	_	_
20	syndromes	_	_	NNS	_	_	_	_	_
21	ranging	_	_	VBG	_	_	_	_	_
22	from	_	_	IN	_	_	_	_	_
23	a	_	_	DT	_	_	_	_	_
24	mild	_	_	JJ	_	_	_	_	_
25	febrile	_	_	JJ	_	_	_	_	_
26	illness	_	_	NN	_	_	_	_	_
27	to	_	_	TO	_	_	_	_	_
28	severe	_	_	JJ	_	_	_	_	_
29	hemorrhagic	_	_	JJ	_	_	_	_	_
30	fever	_	_	NN	_	_	_	_	_
31	or	_	_	CC	_	_	_	_	_
32	neuroinvasive	_	_	JJ	_	_	_	_	_
33	disease	_	_	NN	_	_	_	_	_
34	.	_	_	.	_	_	_	_	_


1	Neurotropic	_	_	JJ	_	_	_	_	_
2	flaviviruses	_	_	NNS	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	such	_	_	JJ	_	_	_	_	_
5	as	_	_	IN	_	_	_	_	_
6	West	_	_	NNP	_	_	_	_	_
7	Nile	_	_	NNP	_	_	_	_	_
8	virus	_	_	NN	_	_	_	_	_
9	(	_	_	-LRB-	_	_	_	_	_
10	WNV	_	_	NNP	_	_	_	_	_
11	)	_	_	-RRB-	_	_	_	_	_
12	,	_	_	,	_	_	_	_	_
13	Japanese	_	_	JJ	_	_	_	_	_
14	encephalitis	_	_	NN	_	_	_	_	_
15	virus	_	_	NN	_	_	_	_	_
16	(	_	_	-LRB-	_	_	_	_	_
17	JEV	_	_	NN	_	_	_	_	_
18	)	_	_	-RRB-	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	and	_	_	CC	_	_	_	_	_
21	tick-borne	_	_	JJ	_	_	_	_	_
22	encephalitis	_	_	NN	_	_	_	_	_
23	virus	_	_	NN	_	_	_	_	_
24	(	_	_	-LRB-	_	_	_	_	_
25	TBEV	_	_	NNP	_	_	_	_	_
26	)	_	_	-RRB-	_	_	_	_	_
27	,	_	_	,	_	_	_	_	_
28	are	_	_	VBP	_	_	_	_	_
29	maintained	_	_	VBN	_	_	_	_	_
30	in	_	_	IN	_	_	_	_	_
31	nature	_	_	NN	_	_	_	_	_
32	in	_	_	IN	_	_	_	_	_
33	transmission	_	_	NN	_	_	_	_	_
34	cycles	_	_	NNS	_	_	_	_	_
35	involving	_	_	VBG	_	_	_	_	_
36	mosquito	_	_	NN	_	_	_	_	_
37	(	_	_	-LRB-	_	_	_	_	_
38	mainly	_	_	RB	_	_	_	_	_
39	Culex	_	_	NNP	_	_	_	_	_
40	spp.	_	_	NN	_	_	_	_	_
41	)	_	_	-RRB-	_	_	_	_	_
42	or	_	_	CC	_	_	_	_	_
43	tick	_	_	NN	_	_	_	_	_
44	(	_	_	-LRB-	_	_	_	_	_
45	mainly	_	_	RB	_	_	_	_	_
46	Ixodes	_	_	NNS	_	_	_	_	_
47	spp.	_	_	NNS	_	_	_	_	_
48	)	_	_	-RRB-	_	_	_	_	_
49	vectors	_	_	NNS	_	_	_	_	_
50	and	_	_	CC	_	_	_	_	_
51	mammalian	_	_	JJ	_	_	_	_	_
52	or	_	_	CC	_	_	_	_	_
53	bird	_	_	NN	_	_	_	_	_
54	amplification	_	_	NN	_	_	_	_	_
55	hosts	_	_	NNS	_	_	_	_	_
56	,	_	_	,	_	_	_	_	_
57	with	_	_	IN	_	_	_	_	_
58	humans	_	_	NNS	_	_	_	_	_
59	serving	_	_	VBG	_	_	_	_	_
60	as	_	_	IN	_	_	_	_	_
61	dead-end	_	_	JJ	_	_	_	_	_
62	incidental	_	_	JJ	_	_	_	_	_
63	hosts	_	_	NNS	_	_	_	_	_
64	.	_	_	.	_	_	_	_	_


1	Most	_	_	JJS	_	_	_	_	_
2	human	_	_	JJ	_	_	_	_	_
3	infections	_	_	NNS	_	_	_	_	_
4	are	_	_	VBP	_	_	_	_	_
5	asymptomatic	_	_	JJ	_	_	_	_	_
6	or	_	_	CC	_	_	_	_	_
7	characterized	_	_	VBN	_	_	_	_	_
8	by	_	_	IN	_	_	_	_	_
9	flu-like	_	_	JJ	_	_	_	_	_
10	illness	_	_	NN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	while	_	_	IN	_	_	_	_	_
13	a	_	_	DT	_	_	_	_	_
14	severe	_	_	JJ	_	_	_	_	_
15	and	_	_	CC	_	_	_	_	_
16	potentially	_	_	RB	_	_	_	_	_
17	fatal	_	_	JJ	_	_	_	_	_
18	neuroinvasive	_	_	JJ	_	_	_	_	_
19	disease	_	_	NN	_	_	_	_	_
20	occurs	_	_	VBZ	_	_	_	_	_
21	in	_	_	IN	_	_	_	_	_
22	a	_	_	DT	_	_	_	_	_
23	minority	_	_	NN	_	_	_	_	_
24	of	_	_	IN	_	_	_	_	_
25	cases	_	_	NNS	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	mostly	_	_	RB	_	_	_	_	_
28	immunocompromised	_	_	JJ	_	_	_	_	_
29	and	_	_	CC	_	_	_	_	_
30	elderly	_	_	JJ	_	_	_	_	_
31	individuals	_	_	NNS	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_


1	Zika	_	_	NNP	_	_	_	_	_
2	virus	_	_	NN	_	_	_	_	_
3	(	_	_	-LRB-	_	_	_	_	_
4	ZIKV	_	_	NNP	_	_	_	_	_
5	)	_	_	-RRB-	_	_	_	_	_
6	has	_	_	VBZ	_	_	_	_	_
7	recently	_	_	RB	_	_	_	_	_
8	drawn	_	_	VBN	_	_	_	_	_
9	attention	_	_	NN	_	_	_	_	_
10	due	_	_	JJ	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	large	_	_	JJ	_	_	_	_	_
14	outbreaks	_	_	NNS	_	_	_	_	_
15	that	_	_	WDT	_	_	_	_	_
16	occurred	_	_	VBD	_	_	_	_	_
17	in	_	_	IN	_	_	_	_	_
18	Pacific	_	_	NNP	_	_	_	_	_
19	Ocean	_	_	NNP	_	_	_	_	_
20	countries	_	_	NNS	_	_	_	_	_
21	and	_	_	CC	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	Americas	_	_	NNPS	_	_	_	_	_
24	.	_	_	.	_	_	_	_	_


1	Like	_	_	IN	_	_	_	_	_
2	other	_	_	JJ	_	_	_	_	_
3	flaviviruses	_	_	NNS	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	ZIKV	_	_	NNP	_	_	_	_	_
6	generally	_	_	RB	_	_	_	_	_
7	causes	_	_	VBZ	_	_	_	_	_
8	asymptomatic	_	_	JJ	_	_	_	_	_
9	infections	_	_	NNS	_	_	_	_	_
10	or	_	_	CC	_	_	_	_	_
11	a	_	_	DT	_	_	_	_	_
12	mild	_	_	JJ	_	_	_	_	_
13	febrile	_	_	JJ	_	_	_	_	_
14	illness	_	_	NN	_	_	_	_	_
15	.	_	_	.	_	_	_	_	_


1	Infection	_	_	NN	_	_	_	_	_
2	during	_	_	IN	_	_	_	_	_
3	pregnancy	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	especially	_	_	RB	_	_	_	_	_
6	during	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	first	_	_	JJ	_	_	_	_	_
9	trimester	_	_	NN	_	_	_	_	_
10	,	_	_	,	_	_	_	_	_
11	causes	_	_	VBZ	_	_	_	_	_
12	fetal	_	_	JJ	_	_	_	_	_
13	microcephaly	_	_	NN	_	_	_	_	_
14	and	_	_	CC	_	_	_	_	_
15	other	_	_	JJ	_	_	_	_	_
16	developmental	_	_	JJ	_	_	_	_	_
17	anomalies	_	_	NNS	_	_	_	_	_
18	,	_	_	,	_	_	_	_	_
19	defined	_	_	VBN	_	_	_	_	_
20	as	_	_	IN	_	_	_	_	_
21	congenital	_	_	JJ	_	_	_	_	_
22	Zika	_	_	NNP	_	_	_	_	_
23	virus	_	_	NN	_	_	_	_	_
24	syndrome	_	_	NN	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_


1	Guillain	_	_	NNP	_	_	_	_	_
2	–	_	_	NNP	_	_	_	_	_
3	Barré	_	_	NNP	_	_	_	_	_
4	syndrome	_	_	NN	_	_	_	_	_
5	and	_	_	CC	_	_	_	_	_
6	meningoencephalitis	_	_	NN	_	_	_	_	_
7	are	_	_	VBP	_	_	_	_	_
8	rare	_	_	JJ	_	_	_	_	_
9	complications	_	_	NNS	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	ZIKV	_	_	NNP	_	_	_	_	_
12	infection	_	_	NN	_	_	_	_	_
13	in	_	_	IN	_	_	_	_	_
14	adult	_	_	JJ	_	_	_	_	_
15	individuals	_	_	NNS	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	ZIKV	_	_	NNP	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	transmitted	_	_	VBN	_	_	_	_	_
4	between	_	_	IN	_	_	_	_	_
5	humans	_	_	NNS	_	_	_	_	_
6	through	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	bite	_	_	NN	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	infected	_	_	VBN	_	_	_	_	_
11	Ae	_	_	NNP	_	_	_	_	_
12	.	_	_	.	_	_	_	_	_
13	aegypti	_	_	FW	_	_	_	_	_
14	and	_	_	CC	_	_	_	_	_
15	other	_	_	JJ	_	_	_	_	_
16	Aedes	_	_	NNP	_	_	_	_	_
17	species	_	_	NNS	_	_	_	_	_
18	mosquitoes	_	_	NNS	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	with	_	_	IN	_	_	_	_	_
21	humans	_	_	NNS	_	_	_	_	_
22	serving	_	_	VBG	_	_	_	_	_
23	as	_	_	IN	_	_	_	_	_
24	amplifying	_	_	VBG	_	_	_	_	_
25	hosts	_	_	NNS	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	Unique	_	_	JJ	_	_	_	_	_
2	among	_	_	IN	_	_	_	_	_
3	flaviviruses	_	_	NNS	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	ZIKV	_	_	NNP	_	_	_	_	_
6	can	_	_	MD	_	_	_	_	_
7	persist	_	_	VB	_	_	_	_	_
8	in	_	_	IN	_	_	_	_	_
9	immune-privileged	_	_	JJ	_	_	_	_	_
10	sites	_	_	NNS	_	_	_	_	_
11	like	_	_	IN	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	testis	_	_	NN	_	_	_	_	_
14	and	_	_	CC	_	_	_	_	_
15	be	_	_	VB	_	_	_	_	_
16	sexually	_	_	RB	_	_	_	_	_
17	transmitted	_	_	VBN	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	addition	_	_	NN	_	_	_	_	_
3	to	_	_	TO	_	_	_	_	_
4	these	_	_	DT	_	_	_	_	_
5	well-known	_	_	JJ	_	_	_	_	_
6	neurotropic	_	_	JJ	_	_	_	_	_
7	flaviviruses	_	_	NNS	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	there	_	_	EX	_	_	_	_	_
10	has	_	_	VBZ	_	_	_	_	_
11	been	_	_	VBN	_	_	_	_	_
12	an	_	_	DT	_	_	_	_	_
13	increasing	_	_	VBG	_	_	_	_	_
14	number	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	reported	_	_	VBN	_	_	_	_	_
17	cases	_	_	NNS	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	neurological	_	_	JJ	_	_	_	_	_
20	complications	_	_	NNS	_	_	_	_	_
21	caused	_	_	VBN	_	_	_	_	_
22	by	_	_	IN	_	_	_	_	_
23	viruses	_	_	NNS	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	such	_	_	JJ	_	_	_	_	_
26	as	_	_	IN	_	_	_	_	_
27	dengue	_	_	NN	_	_	_	_	_
28	virus	_	_	NN	_	_	_	_	_
29	(	_	_	-LRB-	_	_	_	_	_
30	DENV	_	_	NNP	_	_	_	_	_
31	)	_	_	-RRB-	_	_	_	_	_
32	and	_	_	CC	_	_	_	_	_
33	yellow	_	_	JJ	_	_	_	_	_
34	fever	_	_	NN	_	_	_	_	_
35	virus	_	_	NN	_	_	_	_	_
36	(	_	_	-LRB-	_	_	_	_	_
37	YFV	_	_	NNP	_	_	_	_	_
38	)	_	_	-RRB-	_	_	_	_	_
39	,	_	_	,	_	_	_	_	_
40	which	_	_	WDT	_	_	_	_	_
41	usually	_	_	RB	_	_	_	_	_
42	are	_	_	VBP	_	_	_	_	_
43	associated	_	_	VBN	_	_	_	_	_
44	with	_	_	IN	_	_	_	_	_
45	hemorrhagic	_	_	JJ	_	_	_	_	_
46	disease	_	_	NN	_	_	_	_	_
47	.	_	_	.	_	_	_	_	_


1	One	_	_	CD	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	central	_	_	JJ	_	_	_	_	_
5	questions	_	_	NNS	_	_	_	_	_
6	in	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	search	_	_	NN	_	_	_	_	_
9	for	_	_	IN	_	_	_	_	_
10	therapeutic	_	_	JJ	_	_	_	_	_
11	targets	_	_	NNS	_	_	_	_	_
12	for	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	treatment	_	_	NN	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	flaviviral	_	_	JJ	_	_	_	_	_
17	neurological	_	_	JJ	_	_	_	_	_
18	syndromes	_	_	NNS	_	_	_	_	_
19	is	_	_	VBZ	_	_	_	_	_
20	whether	_	_	IN	_	_	_	_	_
21	these	_	_	DT	_	_	_	_	_
22	diseases	_	_	NNS	_	_	_	_	_
23	are	_	_	VBP	_	_	_	_	_
24	induced	_	_	VBN	_	_	_	_	_
25	by	_	_	IN	_	_	_	_	_
26	virus-mediated	_	_	JJ	_	_	_	_	_
27	cytolysis	_	_	NN	_	_	_	_	_
28	,	_	_	,	_	_	_	_	_
29	immune-pathological	_	_	JJ	_	_	_	_	_
30	responses	_	_	NNS	_	_	_	_	_
31	to	_	_	TO	_	_	_	_	_
32	infection	_	_	NN	_	_	_	_	_
33	,	_	_	,	_	_	_	_	_
34	or	_	_	CC	_	_	_	_	_
35	a	_	_	DT	_	_	_	_	_
36	combination	_	_	NN	_	_	_	_	_
37	of	_	_	IN	_	_	_	_	_
38	both	_	_	DT	_	_	_	_	_
39	.	_	_	.	_	_	_	_	_


1	Animal	_	_	NN	_	_	_	_	_
2	models	_	_	NNS	_	_	_	_	_
3	have	_	_	VBP	_	_	_	_	_
4	permitted	_	_	VBN	_	_	_	_	_
5	temporal	_	_	JJ	_	_	_	_	_
6	analysis	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	progressive	_	_	JJ	_	_	_	_	_
10	dissemination	_	_	NN	_	_	_	_	_
11	of	_	_	IN	_	_	_	_	_
12	virus	_	_	NN	_	_	_	_	_
13	infection	_	_	NN	_	_	_	_	_
14	within	_	_	IN	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	CNS	_	_	NN	_	_	_	_	_
17	and	_	_	CC	_	_	_	_	_
18	identification	_	_	NN	_	_	_	_	_
19	of	_	_	IN	_	_	_	_	_
20	cells	_	_	NNS	_	_	_	_	_
21	targeted	_	_	VBN	_	_	_	_	_
22	by	_	_	IN	_	_	_	_	_
23	viral	_	_	JJ	_	_	_	_	_
24	infection	_	_	NN	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	have	_	_	VBP	_	_	_	_	_
27	revealed	_	_	VBN	_	_	_	_	_
28	important	_	_	JJ	_	_	_	_	_
29	details	_	_	NNS	_	_	_	_	_
30	regarding	_	_	VBG	_	_	_	_	_
31	host	_	_	NN	_	_	_	_	_
32	factors	_	_	NNS	_	_	_	_	_
33	that	_	_	WDT	_	_	_	_	_
34	restrict	_	_	VBP	_	_	_	_	_
35	viral	_	_	JJ	_	_	_	_	_
36	replication	_	_	NN	_	_	_	_	_
37	and	_	_	CC	_	_	_	_	_
38	the	_	_	DT	_	_	_	_	_
39	innate	_	_	JJ	_	_	_	_	_
40	and	_	_	CC	_	_	_	_	_
41	adaptive	_	_	JJ	_	_	_	_	_
42	immune	_	_	JJ	_	_	_	_	_
43	responses	_	_	NNS	_	_	_	_	_
44	to	_	_	TO	_	_	_	_	_
45	viral	_	_	JJ	_	_	_	_	_
46	infections	_	_	NNS	_	_	_	_	_
47	,	_	_	,	_	_	_	_	_
48	and	_	_	CC	_	_	_	_	_
49	have	_	_	VBP	_	_	_	_	_
50	been	_	_	VBN	_	_	_	_	_
51	fundamental	_	_	JJ	_	_	_	_	_
52	for	_	_	IN	_	_	_	_	_
53	vaccine	_	_	NN	_	_	_	_	_
54	development	_	_	NN	_	_	_	_	_
55	.	_	_	.	_	_	_	_	_


1	Breakthroughs	_	_	NNS	_	_	_	_	_
2	on	_	_	IN	_	_	_	_	_
3	cell	_	_	NN	_	_	_	_	_
4	reprogramming	_	_	NN	_	_	_	_	_
5	and	_	_	CC	_	_	_	_	_
6	generation	_	_	NN	_	_	_	_	_
7	of	_	_	IN	_	_	_	_	_
8	human	_	_	JJ	_	_	_	_	_
9	induced	_	_	VBN	_	_	_	_	_
10	pluripotent	_	_	JJ	_	_	_	_	_
11	stem	_	_	NN	_	_	_	_	_
12	cells	_	_	NNS	_	_	_	_	_
13	(	_	_	-LRB-	_	_	_	_	_
14	hiPSCs	_	_	NNS	_	_	_	_	_
15	)	_	_	-RRB-	_	_	_	_	_
16	have	_	_	VBP	_	_	_	_	_
17	revolutionized	_	_	VBN	_	_	_	_	_
18	approaches	_	_	NNS	_	_	_	_	_
19	to	_	_	TO	_	_	_	_	_
20	the	_	_	DT	_	_	_	_	_
21	study	_	_	NN	_	_	_	_	_
22	of	_	_	IN	_	_	_	_	_
23	human	_	_	JJ	_	_	_	_	_
24	diseases	_	_	NNS	_	_	_	_	_
25	.	_	_	.	_	_	_	_	_
26	iPSCs	_	_	NNPS	_	_	_	_	_
27	are	_	_	VBP	_	_	_	_	_
28	generated	_	_	VBN	_	_	_	_	_
29	directly	_	_	RB	_	_	_	_	_
30	from	_	_	IN	_	_	_	_	_
31	adult	_	_	JJ	_	_	_	_	_
32	differentiated	_	_	VBN	_	_	_	_	_
33	cells	_	_	NNS	_	_	_	_	_
34	that	_	_	WDT	_	_	_	_	_
35	are	_	_	VBP	_	_	_	_	_
36	reprogrammed	_	_	VBN	_	_	_	_	_
37	back	_	_	RB	_	_	_	_	_
38	into	_	_	IN	_	_	_	_	_
39	an	_	_	DT	_	_	_	_	_
40	embryonic-like	_	_	JJ	_	_	_	_	_
41	pluripotent	_	_	JJ	_	_	_	_	_
42	state	_	_	NN	_	_	_	_	_
43	by	_	_	IN	_	_	_	_	_
44	introducing	_	_	VBG	_	_	_	_	_
45	genes	_	_	NNS	_	_	_	_	_
46	important	_	_	JJ	_	_	_	_	_
47	for	_	_	IN	_	_	_	_	_
48	maintaining	_	_	VBG	_	_	_	_	_
49	the	_	_	DT	_	_	_	_	_
50	essential	_	_	JJ	_	_	_	_	_
51	properties	_	_	NNS	_	_	_	_	_
52	of	_	_	IN	_	_	_	_	_
53	embryonic	_	_	JJ	_	_	_	_	_
54	stem	_	_	NN	_	_	_	_	_
55	cells	_	_	NNS	_	_	_	_	_
56	.	_	_	.	_	_	_	_	_


1	Generation	_	_	NN	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	hiPSCs	_	_	NNS	_	_	_	_	_
4	and	_	_	CC	_	_	_	_	_
5	their	_	_	PRP$	_	_	_	_	_
6	differentiation	_	_	NN	_	_	_	_	_
7	into	_	_	IN	_	_	_	_	_
8	a	_	_	DT	_	_	_	_	_
9	variety	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	cells	_	_	NNS	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	organoids	_	_	NNS	_	_	_	_	_
14	have	_	_	VBP	_	_	_	_	_
15	allow	_	_	VB	_	_	_	_	_
16	to	_	_	TO	_	_	_	_	_
17	set	_	_	VB	_	_	_	_	_
18	up	_	_	RP	_	_	_	_	_
19	versatile	_	_	JJ	_	_	_	_	_
20	,	_	_	,	_	_	_	_	_
21	non-invasive	_	_	JJ	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	ethically	_	_	RB	_	_	_	_	_
24	sustainable	_	_	JJ	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	cruelty-free	_	_	JJ	_	_	_	_	_
27	,	_	_	,	_	_	_	_	_
28	and	_	_	CC	_	_	_	_	_
29	patient-specific	_	_	JJ	_	_	_	_	_
30	models	_	_	NNS	_	_	_	_	_
31	for	_	_	IN	_	_	_	_	_
32	the	_	_	DT	_	_	_	_	_
33	investigation	_	_	NN	_	_	_	_	_
34	of	_	_	IN	_	_	_	_	_
35	the	_	_	DT	_	_	_	_	_
36	mechanisms	_	_	NNS	_	_	_	_	_
37	of	_	_	IN	_	_	_	_	_
38	human	_	_	JJ	_	_	_	_	_
39	diseases	_	_	NNS	_	_	_	_	_
40	,	_	_	,	_	_	_	_	_
41	including	_	_	VBG	_	_	_	_	_
42	viral	_	_	JJ	_	_	_	_	_
43	infections	_	_	NNS	_	_	_	_	_
44	and	_	_	CC	_	_	_	_	_
45	host	_	_	NN	_	_	_	_	_
46	–	_	_	:	_	_	_	_	_
47	pathogen	_	_	NN	_	_	_	_	_
48	interactions	_	_	NNS	_	_	_	_	_
49	,	_	_	,	_	_	_	_	_
50	for	_	_	IN	_	_	_	_	_
51	the	_	_	DT	_	_	_	_	_
52	discovery	_	_	NN	_	_	_	_	_
53	of	_	_	IN	_	_	_	_	_
54	new	_	_	JJ	_	_	_	_	_
55	drugs	_	_	NNS	_	_	_	_	_
56	,	_	_	,	_	_	_	_	_
57	and	_	_	CC	_	_	_	_	_
58	for	_	_	IN	_	_	_	_	_
59	the	_	_	DT	_	_	_	_	_
60	development	_	_	NN	_	_	_	_	_
61	of	_	_	IN	_	_	_	_	_
62	personalized	_	_	VBN	_	_	_	_	_
63	therapies	_	_	NNS	_	_	_	_	_
64	.	_	_	.	_	_	_	_	_


1	Human	_	_	JJ	_	_	_	_	_
2	iPSC-derived	_	_	JJ	_	_	_	_	_
3	neural	_	_	JJ	_	_	_	_	_
4	cells	_	_	NNS	_	_	_	_	_
5	and	_	_	CC	_	_	_	_	_
6	brain	_	_	NN	_	_	_	_	_
7	organoids	_	_	NNS	_	_	_	_	_
8	have	_	_	VBP	_	_	_	_	_
9	been	_	_	VBN	_	_	_	_	_
10	extensively	_	_	RB	_	_	_	_	_
11	used	_	_	VBN	_	_	_	_	_
12	to	_	_	TO	_	_	_	_	_
13	investigate	_	_	VB	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	mechanisms	_	_	NNS	_	_	_	_	_
16	of	_	_	IN	_	_	_	_	_
17	ZIKV	_	_	NN	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	other	_	_	JJ	_	_	_	_	_
20	flavivirus	_	_	NN	_	_	_	_	_
21	infection	_	_	NN	_	_	_	_	_
22	and	_	_	CC	_	_	_	_	_
23	pathogenesis	_	_	NN	_	_	_	_	_
24	and	_	_	CC	_	_	_	_	_
25	have	_	_	VBP	_	_	_	_	_
26	been	_	_	VBN	_	_	_	_	_
27	used	_	_	VBN	_	_	_	_	_
28	as	_	_	IN	_	_	_	_	_
29	platforms	_	_	NNS	_	_	_	_	_
30	to	_	_	TO	_	_	_	_	_
31	discover	_	_	VB	_	_	_	_	_
32	therapeutic	_	_	JJ	_	_	_	_	_
33	targets	_	_	NNS	_	_	_	_	_
34	and	_	_	CC	_	_	_	_	_
35	to	_	_	TO	_	_	_	_	_
36	test	_	_	VB	_	_	_	_	_
37	antiviral	_	_	JJ	_	_	_	_	_
38	compounds	_	_	NNS	_	_	_	_	_
39	.	_	_	.	_	_	_	_	_


1	Initial	_	_	JJ	_	_	_	_	_
2	studies	_	_	NNS	_	_	_	_	_
3	with	_	_	IN	_	_	_	_	_
4	hiPSCs	_	_	NN	_	_	_	_	_
5	studies	_	_	NNS	_	_	_	_	_
6	were	_	_	VBD	_	_	_	_	_
7	crucial	_	_	JJ	_	_	_	_	_
8	to	_	_	TO	_	_	_	_	_
9	provide	_	_	VB	_	_	_	_	_
10	evidence	_	_	NN	_	_	_	_	_
11	of	_	_	IN	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	tropism	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	ZIKV	_	_	NN	_	_	_	_	_
16	for	_	_	IN	_	_	_	_	_
17	human	_	_	JJ	_	_	_	_	_
18	cortical	_	_	JJ	_	_	_	_	_
19	neural	_	_	JJ	_	_	_	_	_
20	progenitor	_	_	NN	_	_	_	_	_
21	cells	_	_	NNS	_	_	_	_	_
22	and	_	_	CC	_	_	_	_	_
23	to	_	_	TO	_	_	_	_	_
24	demonstrate	_	_	VB	_	_	_	_	_
25	that	_	_	IN	_	_	_	_	_
26	ZIKV	_	_	NNP	_	_	_	_	_
27	infection	_	_	NN	_	_	_	_	_
28	impairs	_	_	VBZ	_	_	_	_	_
29	cell	_	_	NN	_	_	_	_	_
30	differentiation	_	_	NN	_	_	_	_	_
31	and	_	_	CC	_	_	_	_	_
32	induces	_	_	VBZ	_	_	_	_	_
33	apoptosis	_	_	NN	_	_	_	_	_
34	,	_	_	,	_	_	_	_	_
35	supporting	_	_	VBG	_	_	_	_	_
36	the	_	_	DT	_	_	_	_	_
37	causative	_	_	JJ	_	_	_	_	_
38	role	_	_	NN	_	_	_	_	_
39	of	_	_	IN	_	_	_	_	_
40	ZIKV	_	_	NN	_	_	_	_	_
41	in	_	_	IN	_	_	_	_	_
42	fetal	_	_	JJ	_	_	_	_	_
43	microcephaly	_	_	NN	_	_	_	_	_
44	.	_	_	.	_	_	_	_	_


1	Human	_	_	JJ	_	_	_	_	_
2	iPSC-derived	_	_	JJ	_	_	_	_	_
3	brain	_	_	NN	_	_	_	_	_
4	organoids	_	_	NNS	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	which	_	_	WDT	_	_	_	_	_
7	are	_	_	VBP	_	_	_	_	_
8	3D	_	_	JJ	_	_	_	_	_
9	structures	_	_	NNS	_	_	_	_	_
10	mimicking	_	_	VBG	_	_	_	_	_
11	endogenous	_	_	JJ	_	_	_	_	_
12	human	_	_	JJ	_	_	_	_	_
13	brain	_	_	NN	_	_	_	_	_
14	development	_	_	NN	_	_	_	_	_
15	and	_	_	CC	_	_	_	_	_
16	organization	_	_	NN	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	showed	_	_	VBD	_	_	_	_	_
19	that	_	_	IN	_	_	_	_	_
20	ZIKV	_	_	NNP	_	_	_	_	_
21	preferentially	_	_	RB	_	_	_	_	_
22	infects	_	_	VBZ	_	_	_	_	_
23	radial	_	_	JJ	_	_	_	_	_
24	glia	_	_	NN	_	_	_	_	_
25	cells	_	_	NNS	_	_	_	_	_
26	as	_	_	IN	_	_	_	_	_
27	compared	_	_	VBN	_	_	_	_	_
28	to	_	_	TO	_	_	_	_	_
29	intermediate	_	_	JJ	_	_	_	_	_
30	progenitors	_	_	NNS	_	_	_	_	_
31	or	_	_	CC	_	_	_	_	_
32	immature	_	_	JJ	_	_	_	_	_
33	neurons	_	_	NNS	_	_	_	_	_
34	,	_	_	,	_	_	_	_	_
35	leading	_	_	VBG	_	_	_	_	_
36	to	_	_	TO	_	_	_	_	_
37	cell	_	_	NN	_	_	_	_	_
38	death	_	_	NN	_	_	_	_	_
39	.	_	_	.	_	_	_	_	_


1	Activation	_	_	NN	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	TLR3-mediated	_	_	JJ	_	_	_	_	_
4	innate	_	_	JJ	_	_	_	_	_
5	immune	_	_	JJ	_	_	_	_	_
6	response	_	_	NN	_	_	_	_	_
7	was	_	_	VBD	_	_	_	_	_
8	one	_	_	CD	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	mechanisms	_	_	NNS	_	_	_	_	_
12	involved	_	_	VBN	_	_	_	_	_
13	ZIKV	_	_	NNP	_	_	_	_	_
14	deleterious	_	_	JJ	_	_	_	_	_
15	effects	_	_	NNS	_	_	_	_	_
16	on	_	_	IN	_	_	_	_	_
17	neurogenesis	_	_	NN	_	_	_	_	_
18	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	addition	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	ability	_	_	NN	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	viruses	_	_	NNS	_	_	_	_	_
8	to	_	_	TO	_	_	_	_	_
9	infect	_	_	VB	_	_	_	_	_
10	and	_	_	CC	_	_	_	_	_
11	replicate	_	_	VB	_	_	_	_	_
12	was	_	_	VBD	_	_	_	_	_
13	found	_	_	VBN	_	_	_	_	_
14	to	_	_	TO	_	_	_	_	_
15	be	_	_	VB	_	_	_	_	_
16	dependent	_	_	JJ	_	_	_	_	_
17	on	_	_	IN	_	_	_	_	_
18	cell	_	_	NN	_	_	_	_	_
19	differentiation	_	_	NN	_	_	_	_	_
20	status	_	_	NN	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	since	_	_	IN	_	_	_	_	_
23	stem	_	_	NN	_	_	_	_	_
24	cells	_	_	NNS	_	_	_	_	_
25	appear	_	_	VBP	_	_	_	_	_
26	to	_	_	TO	_	_	_	_	_
27	be	_	_	VB	_	_	_	_	_
28	refractory	_	_	JJ	_	_	_	_	_
29	to	_	_	TO	_	_	_	_	_
30	viral	_	_	JJ	_	_	_	_	_
31	infection	_	_	NN	_	_	_	_	_
32	probably	_	_	RB	_	_	_	_	_
33	due	_	_	JJ	_	_	_	_	_
34	to	_	_	TO	_	_	_	_	_
35	constitutive	_	_	JJ	_	_	_	_	_
36	high-level	_	_	JJ	_	_	_	_	_
37	expression	_	_	NN	_	_	_	_	_
38	of	_	_	IN	_	_	_	_	_
39	interferon-stimulated	_	_	JJ	_	_	_	_	_
40	genes	_	_	NNS	_	_	_	_	_
41	(	_	_	-LRB-	_	_	_	_	_
42	ISGs	_	_	NNS	_	_	_	_	_
43	)	_	_	-RRB-	_	_	_	_	_
44	,	_	_	,	_	_	_	_	_
45	while	_	_	IN	_	_	_	_	_
46	cell	_	_	NN	_	_	_	_	_
47	susceptibility	_	_	NN	_	_	_	_	_
48	to	_	_	TO	_	_	_	_	_
49	viral	_	_	JJ	_	_	_	_	_
50	infection	_	_	NN	_	_	_	_	_
51	increases	_	_	VBZ	_	_	_	_	_
52	in	_	_	IN	_	_	_	_	_
53	differentiated	_	_	VBN	_	_	_	_	_
54	cells	_	_	NNS	_	_	_	_	_
55	.	_	_	.	_	_	_	_	_


1	Comparisons	_	_	NNS	_	_	_	_	_
2	with	_	_	IN	_	_	_	_	_
3	other	_	_	JJ	_	_	_	_	_
4	flaviviruses	_	_	NNS	_	_	_	_	_
5	—	_	_	:	_	_	_	_	_
6	e.	_	_	FW	_	_	_	_	_
7	g.	_	_	FW	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	DENV	_	_	NNP	_	_	_	_	_
10	—	_	_	:	_	_	_	_	_
11	showed	_	_	VBD	_	_	_	_	_
12	that	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	tropism	_	_	NN	_	_	_	_	_
15	for	_	_	IN	_	_	_	_	_
16	neural	_	_	JJ	_	_	_	_	_
17	stem	_	_	NN	_	_	_	_	_
18	cells	_	_	NNS	_	_	_	_	_
19	was	_	_	VBD	_	_	_	_	_
20	a	_	_	DT	_	_	_	_	_
21	distinguishing	_	_	JJ	_	_	_	_	_
22	feature	_	_	NN	_	_	_	_	_
23	of	_	_	IN	_	_	_	_	_
24	ZIKV	_	_	NNP	_	_	_	_	_
25	,	_	_	,	_	_	_	_	_
26	but	_	_	CC	_	_	_	_	_
27	no	_	_	DT	_	_	_	_	_
28	extensive	_	_	JJ	_	_	_	_	_
29	comparative	_	_	JJ	_	_	_	_	_
30	analyses	_	_	NNS	_	_	_	_	_
31	have	_	_	VBP	_	_	_	_	_
32	been	_	_	VBN	_	_	_	_	_
33	performed	_	_	VBN	_	_	_	_	_
34	with	_	_	IN	_	_	_	_	_
35	typically	_	_	RB	_	_	_	_	_
36	neurotropic	_	_	JJ	_	_	_	_	_
37	flaviviruses	_	_	NNS	_	_	_	_	_
38	like	_	_	IN	_	_	_	_	_
39	WNV	_	_	NNP	_	_	_	_	_
40	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	this	_	_	DT	_	_	_	_	_
3	study	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	we	_	_	PRP	_	_	_	_	_
6	investigated	_	_	VBD	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	infectivity	_	_	NN	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	tropism	_	_	NN	_	_	_	_	_
11	,	_	_	,	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	replication	_	_	NN	_	_	_	_	_
14	kinetics	_	_	NNS	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	ZIKV	_	_	NN	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	in	_	_	IN	_	_	_	_	_
19	comparison	_	_	NN	_	_	_	_	_
20	with	_	_	IN	_	_	_	_	_
21	WNV	_	_	NN	_	_	_	_	_
22	and	_	_	CC	_	_	_	_	_
23	DENV	_	_	NN	_	_	_	_	_
24	in	_	_	IN	_	_	_	_	_
25	hiPSCs	_	_	NNS	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	hiPSCs-derived	_	_	JJ	_	_	_	_	_
28	neural	_	_	JJ	_	_	_	_	_
29	stem	_	_	NN	_	_	_	_	_
30	cells	_	_	NNS	_	_	_	_	_
31	(	_	_	-LRB-	_	_	_	_	_
32	NSCs	_	_	NNP	_	_	_	_	_
33	)	_	_	-RRB-	_	_	_	_	_
34	and	_	_	CC	_	_	_	_	_
35	undifferentiated	_	_	JJ	_	_	_	_	_
36	neurons	_	_	NNS	_	_	_	_	_
37	,	_	_	,	_	_	_	_	_
38	and	_	_	CC	_	_	_	_	_
39	the	_	_	DT	_	_	_	_	_
40	effect	_	_	NN	_	_	_	_	_
41	of	_	_	IN	_	_	_	_	_
42	viral	_	_	JJ	_	_	_	_	_
43	infection	_	_	NN	_	_	_	_	_
44	on	_	_	IN	_	_	_	_	_
45	host	_	_	NN	_	_	_	_	_
46	innate	_	_	JJ	_	_	_	_	_
47	antiviral	_	_	JJ	_	_	_	_	_
48	responses	_	_	NNS	_	_	_	_	_
49	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	addition	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	we	_	_	PRP	_	_	_	_	_
5	exploited	_	_	VBD	_	_	_	_	_
6	hiPSCs	_	_	NNS	_	_	_	_	_
7	to	_	_	TO	_	_	_	_	_
8	model	_	_	NN	_	_	_	_	_
9	ZIKV	_	_	NNP	_	_	_	_	_
10	infection	_	_	NN	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	embryo	_	_	NN	_	_	_	_	_
14	and	_	_	CC	_	_	_	_	_
15	during	_	_	IN	_	_	_	_	_
16	stem	_	_	NN	_	_	_	_	_
17	cell	_	_	NN	_	_	_	_	_
18	differentiation	_	_	NN	_	_	_	_	_
19	towards	_	_	IN	_	_	_	_	_
20	the	_	_	DT	_	_	_	_	_
21	neuronal	_	_	JJ	_	_	_	_	_
22	lineage	_	_	NN	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	results	_	_	NNS	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	this	_	_	DT	_	_	_	_	_
5	study	_	_	NN	_	_	_	_	_
6	confirmed	_	_	VBD	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	tropism	_	_	NN	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	ZIKV	_	_	NNP	_	_	_	_	_
11	for	_	_	IN	_	_	_	_	_
12	NSCs	_	_	NNP	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	but	_	_	CC	_	_	_	_	_
15	showed	_	_	VBD	_	_	_	_	_
16	that	_	_	IN	_	_	_	_	_
17	WNV	_	_	NN	_	_	_	_	_
18	replicated	_	_	VBD	_	_	_	_	_
19	in	_	_	IN	_	_	_	_	_
20	these	_	_	DT	_	_	_	_	_
21	cells	_	_	NNS	_	_	_	_	_
22	with	_	_	IN	_	_	_	_	_
23	much	_	_	RB	_	_	_	_	_
24	higher	_	_	JJR	_	_	_	_	_
25	efficiency	_	_	NN	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	inducing	_	_	VBG	_	_	_	_	_
28	massive	_	_	JJ	_	_	_	_	_
29	cell	_	_	NN	_	_	_	_	_
30	death	_	_	NN	_	_	_	_	_
31	.	_	_	.	_	_	_	_	_


1	Although	_	_	IN	_	_	_	_	_
2	with	_	_	IN	_	_	_	_	_
3	lower	_	_	JJR	_	_	_	_	_
4	efficiency	_	_	NN	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	all	_	_	DT	_	_	_	_	_
7	flaviviruses	_	_	NNS	_	_	_	_	_
8	could	_	_	MD	_	_	_	_	_
9	also	_	_	RB	_	_	_	_	_
10	infect	_	_	VB	_	_	_	_	_
11	pluripotent	_	_	JJ	_	_	_	_	_
12	stem	_	_	NN	_	_	_	_	_
13	cells	_	_	NNS	_	_	_	_	_
14	and	_	_	CC	_	_	_	_	_
15	neurons	_	_	NNS	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	inducing	_	_	VBG	_	_	_	_	_
18	similar	_	_	JJ	_	_	_	_	_
19	patterns	_	_	NNS	_	_	_	_	_
20	of	_	_	IN	_	_	_	_	_
21	antiviral	_	_	JJ	_	_	_	_	_
22	innate	_	_	JJ	_	_	_	_	_
23	immune	_	_	JJ	_	_	_	_	_
24	response	_	_	NN	_	_	_	_	_
25	gene	_	_	NN	_	_	_	_	_
26	expression	_	_	NN	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	While	_	_	IN	_	_	_	_	_
2	showing	_	_	VBG	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	usefulness	_	_	NN	_	_	_	_	_
5	of	_	_	IN	_	_	_	_	_
6	hiPSC-based	_	_	JJ	_	_	_	_	_
7	infection	_	_	NN	_	_	_	_	_
8	models	_	_	NNS	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	these	_	_	DT	_	_	_	_	_
11	findings	_	_	NNS	_	_	_	_	_
12	suggest	_	_	VBP	_	_	_	_	_
13	that	_	_	IN	_	_	_	_	_
14	additional	_	_	JJ	_	_	_	_	_
15	virus-specific	_	_	JJ	_	_	_	_	_
16	mechanisms	_	_	NNS	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	beyond	_	_	IN	_	_	_	_	_
19	neural	_	_	JJ	_	_	_	_	_
20	tropism	_	_	NN	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	are	_	_	VBP	_	_	_	_	_
23	responsible	_	_	JJ	_	_	_	_	_
24	for	_	_	IN	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	peculiarities	_	_	NNS	_	_	_	_	_
27	of	_	_	IN	_	_	_	_	_
28	disease	_	_	NN	_	_	_	_	_
29	phenotype	_	_	NN	_	_	_	_	_
30	in	_	_	IN	_	_	_	_	_
31	humans	_	_	NNS	_	_	_	_	_
32	.	_	_	.	_	_	_	_	_

